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The reliability of gene predictors of cancer outcome has
been recently questioned, pointing to deﬁciencies in experi-
mental design, insufﬁcient statistical power due to small
sample size, and ﬂaws in predictor generation and perfor-
mance assessment, with proposed guidelines to overcome
these limitations (Ntzani and Ioannidis, 2003; Michiels et al,
2005, Dupuy and Simon, 2007). Now, in a recent article
published in Molecular Systems Biology (Chuang et al, 2007), a
complementary strategy has been proposed based on integra-
tion of expression proﬁles with protein interactions, demon-
strating that more reproducible and robust predictors can be
generated with the additional beneﬁt of including mutated
genes which are excluded in the classical analyses, and also
providing models for the molecular mechanisms involved in
metastasisformation. Thisisachievedthroughcombinationof
mRNA expression proﬁles with curated protein–protein
interaction data, which became recently available (Rual et al,
2005), leveraging methods for modular subnetwork identiﬁca-
tion and biological validation (Segal et al, 2003; Poyatos and
Hurst, 2004).
During the past decade, transcriptome analysis has been
used increasingly to monitor expression proﬁles of extensive
collections of genes in cancer samples, providing insights into
the molecular mechanisms underlying cancer development
and outcome. Gene signatures developed from these data sets
allowed characterizationof cancer types and stages,formation
of metastasis or response to therapy with the potential to
complementorevenoutperformtraditionalcellular,molecular
and clinical markers. In early-diagnosed primary breast
cancer, gene predictors from several studies appeared capable
of informing clinicians on the likelihood of metastasis
formation, so that they could eventually restrict exposure of
their patients to aggressive chemotherapy after surgical
removal of the tumor to those cases with poor prognosis.
The expected beneﬁt is to avoidunnecessary secondaryeffects
of the treatment in the large majority of patients for which
chemotherapy is not beneﬁcial.
While large-scale clinical trials are underway to establish
such predictors as prognosis markers for widespread use in
the clinical setting, a number of observations have questioned
their validity, stability or robustness. For example, cross-
comparison of the predictors from two landmark studies
(van’t Veer et al, 2002; Wang et al, 2005) revealed a very
limited overlap with only 3 genes out of 70 or 76 in common,
and much less successful predictions on the other sample
collection. Extensive statistical re-analysis of the two data
sets suggested that differences in the samples analyzed,
the microarray platforms or the data analysis schemes
used were not sufﬁcient to account for these discrepancies,
arguing for the need of analyzing thousands of samples to
obtain largely overlapping gene signatures (Ein-Dor et al,
2006).
The novel strategy described by Trey Ideker and co-workers
(Chuang et al, 2007) is based on the identiﬁcation of protein
interaction subnetworks with coherent expression patterns of
their component genes, which can distinguish the samples of
patients whichdevelopeddistantmetastasisaftersurgeryfrom
those that did not. This is achieved by overlaying protein–
protein interaction data on the gene expression proﬁles,
generating an activity score for protein subnetworks in all
patient samples, then computing the mutual information
betweenactivityscoresand metastasispotentialtoassesstheir
discriminative potential (Figure 1). The prospect is to use the
selected subnetworks as novel markers for prognosis of
metastasis formation in newly diagnosed breast cancer
patients instead of the predictors based on collections of
non-interconnected genes.
Of course, iterative exploration of the high-dimensional
space of all possible protein subnetworks seeded at all nodes
of a highly branched and interconnected network requires
the use of a greedy algorithm. Moreover, it is essential at all
steps of the process to assess statistically the signiﬁcance
and performance of the selected subnetworks for their
discriminative power when compared to randomly generated
or permutated networks and sample classes on one hand,
and to the established predictors on the other hand. This is
also computationally demanding, but not a limiting factor of
the approach with the ever-increasing high-performance
computing power becoming available within laboratory
workstations.
The ﬁndings that are very encouraging is that subnetwork
markers developed by this approach overlap much more
extensively and are more accurate in the classiﬁcation of
metastasis than the previous predictors. An added value of the
approach is that the selected protein subnetworks are
signiﬁcantly enriched in protein involved in common biologi-
cal processes, thus providing potential insights into the
molecular mechanisms involved in metastasis formation. In
addition,thevastmajorityoftheselectedsubnetworkscontain
highly interconnected proteins encoded by genes that are not
bythemselves discriminative, because theyare not detected as
differentially expressed. These include a signiﬁcant number of
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in the established predictors.
The approach proposed by Chuang et al (2007) should now
be complemented by integration with other high-precision
data sets (Hwang et al, 2005). The reported advances are
signiﬁcant, but they also have limitations: the subnetwork
markers selected from the two data sets still overlap only very
partially, and contain only a minority of the cancer suscepti-
bilitygenes.Itiswellpossiblethattheleveland/ormodulation
of expression of many of the functionally relevant genes are
of low magnitude and beyond the detection capabilities of
current microarray technologies. This suggests that there is a
wealth of unexploited information in these and other similar
datasetsavailableinhumanandotherspecies,andcallsforre-
analysis of sufﬁciently powered studies when high-quality
protein–protein interaction data is available. Even more
profound insights can be expected when novel and more
sensitive measurement technologies will become available.
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Figure 1 Identiﬁcation of protein subnetwork markers. Gene expression
proﬁles from metastatic and nonmetastatic tumor sample are overlayed onto a
protein–protein interaction network. Iterative exploration of all possible protein
subnetworks generates an activity score for protein subnetworks in all patient
samples. Computing the mutual information between activity scores and
metastasis potential enables the identiﬁcation of subnetworks with a high
discriminative potential. Statistical signiﬁcance of subnetwork discriminative
power is assessed by comparison with three null distributions obtained by
randomizing gene labels, network structure and sample labels, respectively.
(Figure courtesy of Trey Ideker).
News and Views
C Auffray
2 Molecular Systems Biology 2007 & 2007 EMBO and Nature Publishing Group